Emerging research suggests that curcumin, the active compound in turmeric, may effectively support the activity of alcohol dehydrogenase in a way that protects against liver damage.
Emerging research posits multidonor fecal microbiota transplantation as a promising treatment method for ulcerative colitis and sheds new light the potential of certain nutritional supplements.
Evidence suggests that the IBS home remedies with universal appeal and efficacy focus on supporting the health of the gut microbiome, which can play a role in any and all symptoms of IBS.
As more scientists look to nutritional factors that may aid in the effective management of Parkinson’s disease, quercetin is emerging as a viable treatment option due to its anti-inflammatory and antioxidant effects.
While clinicians have historically suggested low-fiber diets for patients with Crohn’s disease, the latest research suggests that some of the best foods for Crohn’s include those that are high in fiber and combine probiotics with prebiotic fiber.
Preliminary studies suggest that dietary supplements that modulate the gut microbiome or directly introduce metabolites of gut bacteria may to aid in the management of neurodegenerative disorders.
Emerging research suggests that autism-associated behavioral abnormalities are modulated by gut physiology, and dietary supplements like probiotics and short chain fatty acids may prove to be effective therapeutic options.
New research suggests that a bioavailable form of curcumin may have significant effects on patients with neurodegenerative diseases such as dementia, offering new hope to families.
Alternative treatments for autism gives clinicians, parents, and patients new opportunities for creating symptom relief, but any treatment strategy must be tailored to the unique needs of each individual.
Research suggests that quercetin, a flavonoid compound found in many vegetables, fruits, and flowers, may be one of the most promising alternatives to antihistamines.
A recently-developed blood-based peripheral marker that can be used to identify autism-associated ileocolitis could help clinicians develop more effective, patient-specific strategies for symptom management.
For almost two decades, researchers have been conducting rigorous in vitro experiments, animal studies, and clinical trials, to determine whether probiotics could make a difference for patients with IBS.